Check the full story here.
The first phase of clinical trials indicates China’s first AIDS vaccine is safe and possibly effective, government officials announced at the press conference after a two-month-odd assessment.
“Forty-nine healthy people who received the injection showed no severe adverse reactions after 180 days, proving the vaccine was safe,” said Zhang Wei, head of the pharmaceutical registration department of the SFDA.
“The recipients appeared immune to the HIV-1 virus 15 days after the injection, indicating the vaccine worked well in stimulating the body’s immunity,” he told the press conference.
The results mark the end of the first phase of the clinical trials of the AIDS vaccine, which focused on the vaccine’s safety.
Now that is science worth funding.